Section 1 Short title
This Act may be cited as the “Treatment Restoration for Emergency Antibody Therapeutics Act” or the “TREAT Act”.
Treatment Restoration for Emergency Antibody Therapeutics Act
A BILL
To prohibit the Secretary of Health and Human Services from restricting direct access by health care facilities to COVID–19 monoclonal antibody therapies.
Sec. 2 Prohibition on restrictions on direct access to COVID–19 monoclonal antibody therapies
In general— Notwithstanding any other provision of law, the Secretary of Health and Human Services (referred to in this section as the “Secretary”) may not implement or continue in effect any policy that would restrict hospitals or other appropriate health care facilities from ordering and receiving COVID–19 monoclonal antibody therapies directly from manufacturers and distributors of such therapies.
Nullification of certain policy— Pursuant to subsection (a), effective on the date of enactment of this Act, the policy under which the Secretary required hospitals and other facilities to work through State or territorial governments to receive supplies of COVID–19 monoclonal antibody therapies allocated by the Secretary to such States or territories, announced by such Secretary on September 13, 2021, shall have no force or effect.